In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces
Background: Drug repositioning refers to the identification of new indications for existing drugs. Drug-based inference methods for drug repositioning apply some unique features of drugs for new indication prediction. Complementary information is provided by these different features. It is therefore...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |